Effect of remazolam or propofol on the quality of recovery after total hysterectomy in elderly women

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400082880

Enrollment

Unknown

Registered

2024-04-10

Start date

2024-04-10

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panhysterectomy

Interventions

Remazolam group:Anesthetic induction and maintenance of continuous pump remazolam

Propofol group:Anesthetic induction and maintenance of continuous pump propofol

Eligibility

Sex/Gender

Female

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Total hysterectomy under general anesthesia at selected time; 2.American Society of Anesthesiologists Physical Status Classification System (ASA) levels I to III; 3.Age =60 years old.

Exclusion criteria

Exclusion criteria: ? Patients with a known history of allergy to any investigational drug; ?Currently using opioids or sleep AIDS; ? Alcohol dependence; ? Suffering from mental or neurological diseases; ? Illiteracy; ?BMI>30kg/m2; ? Patient rejection.

Design outcomes

Primary

Measure	Time frame
QoR-15 score on the first day after surgery;	—

Secondary

Measure	Time frame
Hemodynamic index;Remazolam dosage;Propofol dosage;RASS score upon arrival in PACU;Postoperative nausea and vomiting;	—

Countries

China

Contacts

Public ContactYang Luyao

Jinan Maternity and Child Care Hospital

byfyyly@163.com+86 198 6185 5597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026